Yukio Nagasaki

Prof. Yukio Nagasaki

Faculty of Pure and Applied Sciences, University of Tsukuba
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2012 in Gastroenterology
Verified
Journal Article
Open access
PDF file
LVLong Binh VONG
Long Binh VONG
TTTsutomu Tomita
Tsutomu Tomita
TYToru Yoshitomi
Toru Yoshitomi
HMHirofumi Matsui
Hirofumi Matsui
YNYukio Nagasaki
Yukio Nagasaki
Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis (UC), affects millions of patients worldwide.1 x 1 Khor, B., Gardet, A., and Xavier, R.J. Genetics and pathogenesis of inflammatory bowel disease. Nat Rev. 2011; 474: 307–317 Google Scholar See all References , 2 x 2 Podolsky, D.K. Inflammatory bowel disease. N Engl J Med. 2002; 347: 417–429 Crossref | PubMed | Scopus (2709) | Google Scholar See all References , 3 x 3 Abraham, C. and Cho, H.J. Mechanism of disease inflammatory bowel disease. N Engl J Med. 2009; 361: 2066–2078 Crossref | PubMed | Scopus (1280) | Google Scholar See all References , 4 x 4 Loftus, E.V. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004; 126: 1504–1517 Abstract | Full Text | Full Text PDF | PubMed | Scopus (1847) | Google Scholar See all References Because the etiology and pathogenesis of IBD are not well understood, it is considered an intractable disease. The intestinal mucosa of patients with IBD is characterized by reactive oxygen species (ROS) overproduction and an imbalance of important antioxidants, leading to oxidative damage. Self-sustaining cycles of oxidant production may amplify inflammation and mucosal injury.5 x 5 Simmonds, N.J. and Rampton, D.S. Inflammatory bowel disease a radical view. Gut. 1993; 34: 865–868 Crossref | PubMed | Scopus (145) | Google Scholar See all References , 6 x 6 Xavier, R.J. and Podolsky, D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nat Rev. 2007; 448: 427–434 Google Scholar See all References , 7 x 7 Babbs, C.F. Oxygen radicals in ulcerative colitis. Free Radic Biol Med. 1992; 13: 169–182 Crossref | PubMed | Scopus (238) | Google Scholar See all References , 8 x 8 McCord, J.M. The evolution of free radicals and oxidative stress. Am J Med. 2000; 108: 652–659 Abstract | Full Text | Full Text PDF | PubMed | Scopus (790) | Google Scholar See all References In several experimental models, antioxidant compounds and free radical scavengers have improved colitis.9 x 9 Jin, Y., Kotakadi, V.S., Ying, L. et al. American ginseng suppresses inflammation and DNA damage associated with mouse colitis. Carcinogenesis. 2008; 29: 2351–2359 Crossref | PubMed | Scopus (44) | Google Scholar See all References , 10 x 10 Ju, J., Hao, X., Lee, M.J. et al. A γ-tocopherol-rich mixture of tocopherols inhibits colon inflammation and carcinogenesis in azoxymethane and dextran sulfate sodium-treated mice. Cancer Prev Re. 2009; 2: 143–152 Crossref | PubMed | Scopus (61) | Google Scholar See all References , 11 x 11 Aggarwal, B.B. and Harikumar, K.B. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009; 41: 40–59 Crossref | PubMed | Scopus (793) | Google Scholar See all References However, these compounds are not completely effective due to a nonspecific drug distribution, low retention in the colon, and side effects. If antioxidant compounds are specifically targeted to the diseased sites and effectively scavenge excessive generated ROS, they represent a safe and effective treatment for IBD.

15 March 2013 in The Analyst
Verified
Journal Article
Closed access
PDF file
TLThangavel Lakshmipriya
Thangavel Lakshmipriya
MFMakoto Fujimaki
Makoto Fujimaki
SGSubash C. B. Gopinath
Subash C. B. Gopinath
KAKoichi Awazu
Koichi Awazu
YHYukichi Horiguchi
Yukichi Horiguchi
YNYukio Nagasaki
Yukio Nagasaki
An evanescent-field-coupled waveguide-mode (EFC-WM) sensor utilizes monolithic SiO2/Si/SiO2 sensing plates having a multilayered structure and is used to evaluate a blocking agent comprising poly(ethylene glycol)-based block copolymers. Factor IX (FIX) protein was detected using its aptamer, viz. FIX was immobilized on a glutaraldehyde-modified silica surface, and then treated with a biotinylated aptamer. The quantitative analysis of FIX was carried out using streptavidin-conjugated gold nanoparticles (SA-GNPs). The blocking polymer, poly(ethylene glycol)-b-poly(acrylic acid) (PEG-b-PAAc), was found to mask unreacted amine and glutaraldehyde (Glu) moieties on the SiO2 surface, and it completely prevented the non-specific binding of SA-GNPs. By exploiting the strong blocking effect of PEG-b-PAAc, we achieved high ligand–analyte interaction sensitivity (sensitive down to 100 pM). To improve the sensitivity further, we also used pentaethylenehexamine-terminated PEG (N6-PEG) on GNPs. The improvement in sensitivity was found to be 1000-fold (to 100 fM), which was substantiated by the observation of higher numbers of GNPs on the sensing surface in the results of the scanning electron microscopic examination. Based on the competition assay of free biotin premixed with SA-GNPs, it was concluded that some active biotin-binding sites on the streptavidin were blocked by N6-PEG, which improved the binding ability to the biotinylated sensing surface. An optimum number of binding sites on the SA-GNPs might improve their binding affinity. The strategy shown with dual polymers, viz. blocking of the sensor chip surface and coating of SA-GNPs, is recommended for developing sensors with higher sensitivity and reliability. Selective binding of the aptamer to a very small amount of FIX in the mixed sample containing FXIa and FVIIa, or albumin, makes this the optimal strategy for detecting a FIX deficiency in human blood samples.

10 July 2007 in Journal of Materials Chemistry
Verified
Journal Article
Closed access
PDF file
MOMotoi Oishi
Motoi Oishi
HHHisato Hayashi
Hisato Hayashi
MIMichihiro Iijima
Michihiro Iijima
YNYukio Nagasaki
Yukio Nagasaki
A pH-sensitive PEGylated nanogel was prepared by emulsion copolymerization of 2-(N,N-diethylamino)ethyl methacrylate (EAMA) with heterobifunctional poly(ethylene glycol) bearing a 4-vinylbenzyl group at the α-end and a carboxylic acid group at the ω-end (CH2 CH–Ph–PEG–COOH; Mn = 8000) in the presence of potassium persulfate and ethylene glycol dimethacrylate (1.0 mol%) as cross-linker. The loading of the anticancer drug doxorubicin (DOX) into the pH-sensitive PEGylated nanogel was carried out by means of a solvent evaporation method, and the amount of DOX loaded into the PEAMA core was found to be 26 wt%. Furthermore, the DOX-loaded, pH-sensitive PEGylated nanogel showed almost no initial burst release of the DOX under physiological pH, whereas significant release of DOX from the pH-sensitive PEGylated nanogel was observed at the endosomal pH. The antitumor activity of the DOX-loaded, pH-sensitive, PEGylated nanogel against the human breast cancer cell line MCF-7 was lower than that of free DOX. On the other hand, the antitumor activity of the DOX-loaded, pH-sensitive, PEGylated nanogel against the human hepatoma cell line HuH-7, which is a natural drug-resistant tumor line, was superior to that of both free DOX and the DOX-loaded, pH-insensitive, PEGylated nanogel. Using fluorescence microscopy, pH-sensitive PEGylated nanogel in HuH-7 cells was found to be initially localized within the endosome and/or lysosome, with subsequent release of DOX from the nanogel in response to the endosomal pH, and ultimately, diffusion via the cytoplasm into the cell nucleus. These findings suggest that the pH-sensitive PEGylated nanogel represents a promising nano-sized carrier for anticancer drug delivery systems in vivo.

19 May 2014 in The Analyst
Verified
Journal Article
Closed access
PDF file
TLThangavel Lakshmipriya
Thangavel Lakshmipriya
YHYukichi Horiguchi
Yukichi Horiguchi
YNYukio Nagasaki
Yukio Nagasaki
In order to detect an extremely low amount of human coagulation factor IX (FIX), poly(ethylene glycol) (PEG)/aptamer co-immobilized surface was constructed using original PEG–polyamine surface modification agents on surface plasmon resonance (SPR) sensor chip. Initially, a gold (Au) sensor chip of SPR was modified using poly(ethylene glycol)-b-poly[2-(N,N-dimethylamino)ethyl methacrylate] (PEG-b-PAMA) followed by treatment with SH-dT20 and was duplexed with anti-FIX aptamer extended using A24. Furthermore, the co-immobilization of pentaethylenehexamine-terminated poly(ethylene glycol) (N6-PEG) on the sensing surface completely quenched bio-fouling. On this dual tethered PEG-surface, we determined that the dissociation constant for FIX–aptamer interaction was 37 ± 10 pM, and the sensitivity of detection could reach up to 800 fM on using aptamer–FIX–antibody sandwich pattern detected by gold nanoparticle-conjugated anti-mouse antibody. We could detect FIX in the presence of abundant albumin. Furthermore, to mimic the actual detection of FIX in clinical samples, we demonstrated our experimental results with human blood plasma instead of FIX. Higher-sensitivity was attained because of dual polymers immobilized on Au surface, and this can emerge as a common strategy for any aptamer–protein interactions. The selective binding of aptamer in human blood plasma described here indicates the suitability of the present strategy for detection in clinically relevant samples.

1 June 2018 in Biomaterials
Verified
Journal Article
Closed access
LVLong Binh VONG
Long Binh VONG
TBThang Quoc Bui
Thang Quoc Bui
TTTsutomu Tomita
Tsutomu Tomita
HSHiroaki Sakamoto
Hiroaki Sakamoto
YHYuji Hiramatsu
Yuji Hiramatsu
YNYukio Nagasaki
Yukio Nagasaki

5 October 2011 in Polymer Journal
Verified
Journal Article
Open access
PDF file
YNYukio Nagasaki
Yukio Nagasaki
Non-biofouling surfaces constitute one of the most important subjects in sensitively and selectively detecting biomolecular events. Poly(ethylene glycol) (PEG) chains tethered on substrate surfaces are well known to reduce non-biofouling characteristics. Protein adsorption onto a PEG-chain-tethered surface is strongly influenced by the density of the PEG chain and is almost completely suppressed by the successive treatment of longer PEG chains (5 kDa) followed by the treatment of PEG (2 kDa; mixed-PEG-chain-tethered surface) because of a significant increase in PEG chain density. To modify versatile substrate surface, PEG possessing pentaethylenehexamine at one end (N6-PEG) was prepared via a reductive amination reaction of aldehyde-ended PEG with pentaethylenehexamine. Using N6-PEG, antibody/PEG co-immobilization was conducted on a substrate possessing active ester groups. After the antibody was immobilized on the surface, PEG tethered chains were constructed surrounding the immobilized antibody. It is interesting to note that the PEG-chain-tethered functions not only as a non-fouling agent but also improves immune response. The hybrid surface was also applied to oligo DNA immobilization. The oligo DNA/PEG hybrid surface improved hybridization, retaining its non-fouling ability. Densely packed PEG tethered chains surrounding antibodies and/or oligo DNA improved their orientation on the surface. Thus, this material is promising as a high-performance biointerface for versatile applications.